https://kb.clinicalpathways.io 2024-10-05T14:43:37+00:00 1.0 https://kb.clinicalpathways.io/guidance 2023-11-13T09:54:09+00:00 0.5 https://kb.clinicalpathways.io/guidance/lch-diabetes-service-sop-oral-hypoglycaemic-agents-and-glp-1-receptor-agonists 2024-06-16T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/guidance/template 2024-06-16T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/guidance/hypertension-ng136 2024-06-16T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/guidance/test 2024-09-08T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/illness-script 2024-08-29T17:39:13+00:00 0.5 https://kb.clinicalpathways.io/illness-script/template 2024-08-29T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/illness-script/illness-scripts-explained 2024-10-05T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/diabetes 2023-10-28T10:56:59+00:00 0.5 https://kb.clinicalpathways.io/diabetes/test-divs 2024-06-16T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/diabetes/hypertension-template 2024-06-16T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/diabetes/hypertension 2024-06-16T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/diabetes/hypertension-highlights 2024-06-16T00:00:00+00:00 0.5 https://kb.clinicalpathways.io/diabetes/ng136 2024-06-16T00:00:00+00:00 0.5